BioSpace News Archive

Business

Intersect ENT Reports Preliminary Q4 and Year 2017 Revenue

Intersect ENT today reported preliminary unaudited revenue for the fourth quarter and year ended December 31, 2017.

January 8, 2018
·
3 min read
Business

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017

Preliminary and unaudited revenue for fourth quarter 2017 is expected to be approximately $46.1 million, reflecting growth of approximately 12% over the fourth quarter of 2016.

January 8, 2018
·
3 min read
Business

Ocular Therapeutix Announces Kevin Hanley as Senior Vice President, Technical Operations and Naymisha Patel as Vice President of Quality

Kevin Hanley brings over 30 years of experience managing biotechnology and pharmaceutical operations with demonstrated success in technology transfer and process scale-up for the manufacturing of proteins from development through commercialization.

January 8, 2018
·
6 min read
Biotech Bay

Aimmune Therapeutics Announces 2018 Outlook, Including Upcoming Data from Pivotal Phase III PALISADE Trial of AR101 for Peanut Allergy

Following expected topline results in February, Aimmune will report more detailed data from the PALISADE trial in a late-breaking oral abstract presentation on Sunday, March 4, 2018, at the American Academy of Allergy, Asthma & Immunology–World Allergy Organization Joint Congress in Orlando.

January 8, 2018
·
7 min read
Business

Pfizer Establishes New Partnering Model for Early-Stage Academic Research

Pfizer Inc. today announced the creation of the Innovative Target Exploration Network (ITEN), a new, early-stage partnering model that enables collaborative relationships with select academic institutions and principal investigators around the world.

January 8, 2018
·
6 min read
Lone Star Bio

Castle Biosciences Launches Next-Generation Sequencing Panel DecisionDx-UMSeq for Uveal Melanoma

The new test will complement Castle Biosciences’ standard-of-care DecisionDx-UM gene expression profile (GEP) test that has been shown to be independent of and superior to mutational analysis in assessing likelihood of metastasis in UM.

January 8, 2018
·
4 min read
Business

Tricida Announces Hiring of Jeroen van Beek, Ph.D., as Chief Commercial Officer and Senior Vice President

Dr. van Beek will lead Tricida’s commercial planning and operations functions.

January 8, 2018
·
3 min read
Genetown

Syros Announces 2018 Strategic Priorities and Expected Milestones

In a presentation at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018, at 10:30 a.m. PST.

January 8, 2018
·
9 min read
Business

Harbour BioMed Enters Agreement to Develop Fully Human Antibody Fragments for Innovative CAR-T Therapy

Under the agreement, ImmunoChina receives rights to use the fully human antibody fragments discovered by Harbour BioMed through its H2L2 transgenic mouse platform for the development of CAR-T based therapeutic solutions.

January 8, 2018
·
3 min read
Pharm Country

Alexandria Venture Investments Launches the Alexandria Seed Capital Platform, a Novel and Innovative Seed-Stage Life Science Funding Model and a Natural Extension of Alexandria LaunchLabs

The Alexandria Seed Capital Platform will be led by Alexandria Venture Investments and supported by a preeminent Advisory Board of seasoned biopharma and venture capital executives from Accelerator Life Science Partners, ARCH Venture Partners, Eli Lilly and Company, Pfizer and Roche.

January 8, 2018
·
6 min read